2002
DOI: 10.1038/sj.eye.6700213
|View full text |Cite
|
Sign up to set email alerts
|

Squamous cell carcinoma of the eyelid in a renal transplant patient

Abstract: patients with documented malignant hematologic disorders for a second malignancy. References

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…2,68,70 Immunosuppression is a well-known risk factor for SCC, and eyelid SCC has been reported in renal transplant recipients and individuals with the human immunodeficiency virus (HIV). 71,72 Immunocompromised patients have higher rates of SCC metastasis and death. 72,73 There are numerous histologic variants of SCC, including but not limited to Bowen's disease (SCC in situ, SCCIS), invasive, acantholytic, and keratoacanthoma (KA).…”
Section: Squamous Cell Carcinomamentioning
confidence: 99%
“…2,68,70 Immunosuppression is a well-known risk factor for SCC, and eyelid SCC has been reported in renal transplant recipients and individuals with the human immunodeficiency virus (HIV). 71,72 Immunocompromised patients have higher rates of SCC metastasis and death. 72,73 There are numerous histologic variants of SCC, including but not limited to Bowen's disease (SCC in situ, SCCIS), invasive, acantholytic, and keratoacanthoma (KA).…”
Section: Squamous Cell Carcinomamentioning
confidence: 99%